Featured Research

from universities, journals, and other organizations

Immune Response To HIV May Be Better Than Previously Thought

Date:
February 17, 1998
Source:
Johns Hopkins Medical Institutions
Summary:
A Johns Hopkins study using genetically engineered cells strongly suggests that long-term survivors' immunity to HIV is more robust than previously thought.

A Johns Hopkins study using genetically engineered cells strongly suggests that long-term survivors' immunity to HIV is more robust than previously thought.

One implication is that some experimental vaccines may be better than standard tests have shown, according to Stuart Ray, M.D., assistant professor in the division of infectious diseases. The results of the study, published in the Jan. 1 issue of AIDS and Human Retroviruses, also offer clues to why some infected with HIV live much longer than others. The work was supported in part by the National Institute of Allergy and Infectious Diseases.

The Hopkins scientists suspected that standard methods of measuring anti-HIV reaction by immune cells in the body were inadequate because the tests used laboratory strains of the AIDS virus rather than strains that actually infect people.

"Some proteins on the surface of lab strains of the virus differed from the natural strains," says Ray. "So there was the probability that results of standard tests wouldn't reflect accurately how well the immune system responds to an infection or to a vaccine. It made sense to test a person's immune response by using proteins from the same virus that he was infected with, rather than a laboratory strain."

Based on that hunch, the Hopkins scientists stimulated immune cells called CTLs taken from AIDS patients, using proteins from the same strain of HIV that infected them. CTLs are an important defense against HIV and attack the virus early in an infection, before anti-HIV antibodies appear, according to Ray.

To do this, the Hopkins team used genes from those viruses to genetically engineer a type of immune system cell called B cells, which were also taken from those patients. The B cells used the genes to make a type of HIV protein called Env, which is known to be an important target of the immune system. The scientists then stimulated the patients' CTLs by exposing them to the B cells carrying Env on their surfaces. The Env protein differs somewhat in different strains of HIV. Such mutations usually let the virus "hide" from anti-HIV antibodies made by the immune system. But the Hopkins researchers found that CTLs aren't so easily fooled.

"We found using this new test that people who are infected have a better immune response to HIV than previously thought," Ray says. "Different clones, or families, of CTLs from people infected with HIV become activated during an infection, and these clones can recognize a slightly different version of Env. These clones may recognize various strains of HIV even if they have not been previously exposed to them. That means the immune response to HIV is more robust than previously thought. And it means that the response to a vaccine carrying Env may be more robust as well."

Other authors of the study include Ndongala Lubaki, Bharati R. Dhruva, Robert F. Siliciano and Robert C. Bollinger.


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Immune Response To HIV May Be Better Than Previously Thought." ScienceDaily. ScienceDaily, 17 February 1998. <www.sciencedaily.com/releases/1998/02/980217131717.htm>.
Johns Hopkins Medical Institutions. (1998, February 17). Immune Response To HIV May Be Better Than Previously Thought. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/1998/02/980217131717.htm
Johns Hopkins Medical Institutions. "Immune Response To HIV May Be Better Than Previously Thought." ScienceDaily. www.sciencedaily.com/releases/1998/02/980217131717.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins